JD HEALTH
06618
BEKE-W
02423
JD-SW
09618
XIAOMI-W
01810
TRIP.COM-S
09961
(Q6)Oct 31, 2024 | (FY)Apr 30, 2024 | (Q6)Oct 31, 2023 | (FY)Apr 30, 2023 | (Q6)Oct 31, 2022 | (FY)Apr 30, 2022 | (Q6)Oct 31, 2021 | (FY)Apr 30, 2021 | (Q6)Oct 31, 2020 | (FY)Apr 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -24.92%64.39M | -17.71%122.91M | 45.59%85.77M | -11.56%149.36M | -16.81%58.91M | 39.66%168.89M | 45.38%70.82M | -53.00%120.93M | -65.95%48.71M | 25.90%257.32M |
Operating income | -24.92%64.39M | -17.71%122.91M | 45.59%85.77M | -11.56%149.36M | -16.81%58.91M | 39.66%168.89M | 45.38%70.82M | -53.00%120.93M | -65.95%48.71M | 25.90%257.32M |
Cost of sales | 26.56%-57.64M | 19.97%-104.59M | -62.46%-78.48M | 2.85%-130.69M | 10.99%-48.31M | -32.53%-134.53M | -38.14%-54.27M | 48.48%-101.51M | 63.60%-39.29M | -28.15%-197.03M |
Operating expenses | 26.56%-57.64M | 19.97%-104.59M | -62.46%-78.48M | 2.85%-130.69M | 10.99%-48.31M | -32.53%-134.53M | -38.14%-54.27M | 48.48%-101.51M | 63.60%-39.29M | -28.15%-197.03M |
Gross profit | -7.26%6.76M | -1.90%18.32M | -31.28%7.29M | -45.66%18.67M | -35.93%10.6M | 76.90%34.36M | 75.54%16.55M | -67.78%19.43M | -73.18%9.43M | 19.07%60.29M |
Selling expenses | -0.82%-7.1M | -11.86%-15.41M | -17.73%-7.04M | 7.13%-13.77M | 23.11%-5.98M | -59.95%-14.83M | -61.54%-7.78M | 44.55%-9.27M | 39.05%-4.81M | -80.19%-16.72M |
Administrative expenses | 6.33%-8.08M | 3.00%-17.18M | 3.31%-8.63M | 7.15%-17.71M | -2.47%-8.92M | -37.22%-19.07M | -40.28%-8.71M | 12.45%-13.9M | 9.48%-6.21M | -56.63%-15.87M |
Revaluation surplus | 80.71%-346K | ---- | 15.50%-1.79M | ---- | -1,171.26%-2.12M | ---- | -125.38%-167K | ---- | --658K | ---- |
-Changes in the fair value of financial assets | 80.71%-346K | ---- | 15.50%-1.79M | ---- | -1,171.26%-2.12M | ---- | -125.38%-167K | ---- | --658K | ---- |
Impairment and provision | -126.85%-1.69M | -402.18%-1.38M | -830.39%-745K | -139.45%-275K | 114.07%102K | -44.15%697K | -162.07%-725K | 131.29%1.25M | 176.99%1.17M | -377.98%-3.99M |
-Other impairment is provision | -126.85%-1.69M | -402.18%-1.38M | -830.39%-745K | -139.45%-275K | 114.07%102K | -44.15%697K | -162.07%-725K | 131.29%1.25M | 176.99%1.17M | -377.98%-3.99M |
Special items of operating profit | 102.37%1.45M | 52.27%-1.47M | -67.72%717K | -1,099.35%-3.09M | 48.76%2.22M | -91.87%309K | 102.30%1.49M | 193.12%3.8M | 136.25%738K | 49.57%-4.08M |
Operating profit | 11.72%-9.01M | -5.87%-17.12M | -148.93%-10.2M | -1,203.07%-16.17M | -714.39%-4.1M | 12.42%1.47M | -31.31%667K | -93.35%1.3M | -94.23%971K | -20.09%19.62M |
Financing cost | -12.62%-116K | 30.92%-239K | 44.62%-103K | -46.61%-346K | -48.80%-186K | 6.72%-236K | -0.81%-125K | -24.02%-253K | -37.78%-124K | -2,814.29%-204K |
Earning before tax | 11.48%-9.12M | -5.10%-17.36M | -140.52%-10.3M | -1,442.85%-16.52M | -890.41%-4.28M | 17.03%1.23M | -36.01%542K | -94.59%1.05M | -94.94%847K | -20.90%19.42M |
Tax | -13.00%87K | 135.56%212K | 194.12%100K | 112.18%90K | 102.91%34K | 35.12%-739K | -134.07%-1.17M | 68.16%-1.14M | 87.46%-499K | 42.57%-3.58M |
After-tax profit from continuing operations | 11.47%-9.03M | -4.38%-17.15M | -140.09%-10.2M | -3,445.62%-16.43M | -578.91%-4.25M | 657.95%491K | -279.89%-626K | -100.56%-88K | -97.28%348K | -13.54%15.84M |
Earning after tax | 11.47%-9.03M | -4.38%-17.15M | -140.09%-10.2M | -3,445.62%-16.43M | -578.91%-4.25M | 657.95%491K | -279.89%-626K | -100.56%-88K | -97.28%348K | -13.54%15.84M |
Profit attributable to shareholders | 11.47%-9.03M | -4.38%-17.15M | -140.09%-10.2M | -3,445.62%-16.43M | -578.91%-4.25M | 657.95%491K | -279.89%-626K | -100.56%-88K | -97.28%348K | -13.54%15.84M |
Basic earnings per share | 12.50%-0.28 | -4.48%-0.536 | -146.15%-0.32 | -3,520.00%-0.513 | -550.00%-0.13 | 600.00%0.015 | -300.00%-0.02 | -100.60%-0.003 | -97.50%0.01 | -12.28%0.5 |
Diluted earnings per share | 12.50%-0.28 | -4.48%-0.536 | -146.15%-0.32 | -3,520.00%-0.513 | -550.00%-0.13 | 600.00%0.015 | -300.00%-0.02 | -100.60%-0.003 | -97.50%0.01 | 0.5 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.